{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:41:02Z","timestamp":1774568462940,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.kint.2017.02.017","type":"journal-article","created":{"date-parts":[[2017,4,14]],"date-time":"2017-04-14T20:30:49Z","timestamp":1492201849000},"page":"657-668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["B-type natriuretic peptide overexpression ameliorates hepatorenal fibrocystic disease in\u00a0a\u00a0rat\u00a0model of polycystic kidney disease"],"prefix":"10.1016","volume":"92","author":[{"given":"Sara J.","family":"Holditch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire A.","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas F.","family":"LaRusso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Ramirez-Alvarado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Cataliotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente E.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2017.02.017_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2015.59","article-title":"Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"88","author":"Chapman","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.02.017_bib2","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(15)60907-2","article-title":"Autosomal dominant polycystic kidney disease: the changing face of clinical management","volume":"385","author":"Ong","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2017.02.017_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.md.0000200165.90373.9a","article-title":"Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD)","volume":"85","author":"Adeva","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.kint.2017.02.017_bib4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/sj.ki.5002695","article-title":"Calcium, cyclic AMP, and MAP kinases: dysregulation in polycystic kidney disease","volume":"73","author":"Cowley","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.02.017_bib5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.molmed.2014.01.004","article-title":"Polycystin-1: a master regulator of intersecting cystic pathways","volume":"20","author":"Fedeles","year":"2014","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.kint.2017.02.017_bib6","first-page":"H1049","article-title":"Coronary vasodilator effects of BNP: mechanisms of action in coronary conductance and resistance arteries","volume":"276","author":"Zellner","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.kint.2017.02.017_bib7","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1172\/JCI118092","article-title":"Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression","volume":"96","author":"Fujisaki","year":"1995","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2017.02.017_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1161\/HYPERTENSIONAHA.115.05610","article-title":"B-type natriuretic peptide deletion leads to progressive hypertension, associated organ damage, and reduced survival: novel model for human hypertension","volume":"66","author":"Holditch","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2017.02.017_bib9","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1681\/ASN.V12122652","article-title":"Overexpression of brain natriuretic peptide in mice ameliorates immune-mediated renal injury","volume":"12","author":"Suganami","year":"2001","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.02.017_bib10","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1007\/s00125-006-0352-y","article-title":"Transgenic overexpression of brain natriuretic peptide prevents the progression of diabetic nephropathy in mice","volume":"49","author":"Makino","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.kint.2017.02.017_bib11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ki.2009.438","article-title":"Cyclic nucleotide signaling in polycystic kidney disease","volume":"77","author":"Wang","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.02.017_bib12","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1681\/ASN.V1171179","article-title":"cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells","volume":"11","author":"Hanaoka","year":"2000","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.02.017_bib13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1523-1755.2001.00473.x","article-title":"The pck rat: a new model that resembles human autosomal dominant polycystic kidney and liver disease","volume":"59","author":"Lager","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.02.017_bib14","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/ng833","article-title":"The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein","volume":"30","author":"Ward","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.kint.2017.02.017_bib15","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1161\/CIRCULATIONAHA.110.981720","article-title":"Long-term cardiac pro-B-type natriuretic peptide gene delivery prevents the development of hypertensive heart disease in spontaneously hypertensive rats","volume":"123","author":"Cataliotti","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2017.02.017_bib16","doi-asserted-by":"crossref","first-page":"7403","DOI":"10.1073\/pnas.96.13.7403","article-title":"The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system","volume":"96","author":"Matsukawa","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2017.02.017_bib17","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.2337\/dc12-2165","article-title":"Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-31)","volume":"36","author":"Riphagen","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2017.02.017_bib18","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/nep.12261","article-title":"Blockade of interleukin-8 receptor signalling inhibits cyst development in\u00a0vitro, via suppression of cell proliferation in autosomal polycystic kidney disease","volume":"19","author":"Lee","year":"2014","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.kint.2017.02.017_bib19","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.bbadis.2006.04.006","article-title":"Inhibition of HER-2(neu\/ErbB2) restores normal function and structure to polycystic kidney disease (PKD) epithelia","volume":"1762","author":"Wilson","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.kint.2017.02.017_bib20","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(01)06531-X","article-title":"Autosomal dominant polycystic kidney disease: modification of disease progression","volume":"358","author":"Peters","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2017.02.017_bib21","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/j.febslet.2009.05.025","article-title":"Inhibition of hepatic damage and liver fibrosis by brain natriuretic peptide","volume":"583","author":"Sonoyama","year":"2009","journal-title":"FEBS Lett"},{"key":"10.1016\/j.kint.2017.02.017_bib22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/jcp.22253","article-title":"B-type natriuretic peptide and extracellular matrix protein interactions in human cardiac fibroblasts","volume":"225","author":"Huntley","year":"2010","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.kint.2017.02.017_bib23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.yjmcc.2014.08.001","article-title":"Cardiac fibrosis in end-stage human heart failure and the cardiac natriuretic peptide guanylyl cyclase system: regulation and therapeutic implications","volume":"75","author":"Ichiki","year":"2014","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.kint.2017.02.017_bib24","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1073\/pnas.070371497","article-title":"Cardiac fibrosis in mice lacking brain natriuretic peptide","volume":"97","author":"Tamura","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2017.02.017_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/path.2734","article-title":"Elevated TGFbeta-Smad signalling in experimental Pkd1 models and human patients with polycystic kidney disease","volume":"222","author":"Hassane","year":"2010","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.kint.2017.02.017_bib26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1681\/ASN.2012050486","article-title":"A\u00a0Pkd1-Fbn1 genetic interaction implicates TGF-beta signaling in the pathogenesis of vascular complications in autosomal dominant polycystic kidney disease","volume":"25","author":"Liu","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.02.017_bib27","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1681\/ASN.2015030287","article-title":"Inhibition of activin signaling slows progression of polycystic kidney disease","volume":"27","author":"Leonhard","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.02.017_bib28","doi-asserted-by":"crossref","first-page":"40419","DOI":"10.1074\/jbc.M405079200","article-title":"Calcium restriction allows cAMP activation of the B-Raf\/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype","volume":"279","author":"Yamaguchi","year":"2004","journal-title":"J\u00a0Bio Chem"},{"key":"10.1016\/j.kint.2017.02.017_bib29","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1681\/ASN.2005060645","article-title":"Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells","volume":"17","author":"Yamaguchi","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.02.017_bib30","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1681\/ASN.2007060665","article-title":"Src inhibition ameliorates polycystic kidney disease","volume":"19","author":"Sweeney","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.02.017_bib31","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3892\/or.2012.1899","article-title":"Silencing of miR-1-1 and miR-133a-2 cluster expression by DNA hypermethylation in colorectal cancer","volume":"28","author":"Chen","year":"2012","journal-title":"Oncol Rep"},{"key":"10.1016\/j.kint.2017.02.017_bib32","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.3892\/mmr.2013.1319","article-title":"Type II, but not type I, cGMP-dependent protein kinase reverses bFGF-induced proliferation and migration of U251 human glioma cells","volume":"7","author":"Cao","year":"2013","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.kint.2017.02.017_bib33","doi-asserted-by":"crossref","first-page":"13414","DOI":"10.1073\/pnas.94.25.13414","article-title":"Catalytic mechanism of the adenylyl and guanylyl cyclases: modeling and mutational analysis","volume":"94","author":"Liu","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2017.02.017_bib34","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1681\/ASN.2015010047","article-title":"Phosphodiesterase isoform regulation of cell proliferation and fluid secretion in autosomal dominant polycystic kidney disease","volume":"27","author":"Pinto","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.02.017_bib35","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1124\/jpet.114.214882","article-title":"Different compartmentation of responses to brain natriuretic peptide and C-type natriuretic peptide in failing rat ventricle","volume":"350","author":"Moltzau","year":"2014","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.kint.2017.02.017_bib36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.regpep.2012.11.001","article-title":"cGMP-PDE3-cAMP signal pathway involved in the inhibitory effect of CNP on gastric motility in rat","volume":"180","author":"Cai","year":"2013","journal-title":"Regul Pept"},{"key":"10.1016\/j.kint.2017.02.017_bib37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.regpep.2007.02.004","article-title":"Altered role of C-type natriuretic peptide-activated pGC-cGMP-PDE3-cAMP signaling in hyperthyroid beating rabbit atria","volume":"142","author":"Wen","year":"2007","journal-title":"Regul Pept"},{"key":"10.1016\/j.kint.2017.02.017_bib38","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00280-015-2734-7","article-title":"Protective effects of C-type natriuretic peptide on cisplatin-induced nephrotoxicity in mice","volume":"75","author":"Kimura","year":"2015","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.kint.2017.02.017_bib39","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/01.HYP.0000033974.57407.82","article-title":"Association of eNOS Glu298Asp polymorphism with end-stage renal disease","volume":"40","author":"Noiri","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2017.02.017_bib40","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1073\/pnas.88.4.1197","article-title":"Ca2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes","volume":"88","author":"Mery","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2017.02.017_bib41","doi-asserted-by":"crossref","first-page":"11363","DOI":"10.1073\/pnas.162100799","article-title":"Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes","volume":"99","author":"Fiedler","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2017.02.017_bib42","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1172\/JCI118837","article-title":"Expression of type II cGMP-dependent protein kinase in rat kidney is regulated by dehydration and correlated with renin gene expression","volume":"98","author":"Gambaryan","year":"1996","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2017.02.017_bib43","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1073\/pnas.96.11.6084","article-title":"Atrial natriuretic peptide-stimulated Ca2+ reabsorption in rabbit kidney requires membrane-targeted, cGMP-dependent protein kinase type II","volume":"96","author":"Hoenderop","year":"1999","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.kint.2017.02.017_bib44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0896-6273(92)90104-L","article-title":"Nitric oxide, a novel neuronal messenger","volume":"8","author":"Bredt","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.kint.2017.02.017_bib45","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1042\/bj3180849","article-title":"3\u2032:5\u2032-cyclic guanosine monophosphate (cGMP) potentiates the inositol 1,4,5-trisphosphate-evoked Ca2+ release in guinea-pig hepatocytes","volume":"318","author":"Guihard","year":"1996","journal-title":"Biochem J"},{"key":"10.1016\/j.kint.2017.02.017_bib46","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/sj.mt.6300081","article-title":"Efficient whole-body transduction with trans-splicing adeno-associated viral vectors","volume":"15","author":"Ghosh","year":"2007","journal-title":"Mol Ther"},{"key":"10.1016\/j.kint.2017.02.017_bib47","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1038\/mt.2008.207","article-title":"A\u00a0single intravenous injection of adeno-associated virus serotype-9 leads to whole body skeletal muscle transduction in dogs","volume":"16","author":"Yue","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.kint.2017.02.017_bib48","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nbt0909-804","article-title":"The neonatal blood-brain barrier is functionally effective, and immaturity does not explain differential targeting of AAV9","volume":"27","author":"Saunders","year":"2009","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.kint.2017.02.017_bib49","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/mt.2012.200","article-title":"Improved survival and reduced phenotypic severity following AAV9\/MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout mice","volume":"21","author":"Gadalla","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.kint.2017.02.017_bib50","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1681\/ASN.2013040398","article-title":"Strategies targeting cAMP signaling in the treatment of polycystic kidney disease","volume":"25","author":"Torres","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253817301503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253817301503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:48:55Z","timestamp":1758761335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253817301503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0085253817301503"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2017.02.017","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727521408.793532955","asserted-by":"object"}]},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"B-type natriuretic peptide overexpression ameliorates hepatorenal fibrocystic disease in\u00a0a\u00a0rat\u00a0model of polycystic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2017.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}